This is a focused update highlighting the most current NCCN Guidelines for diagnosis and management of Lynch syndrome. Lynch syndrome is the most common cause of hereditary colorectal cancer, usually resulting from a germline mutation in 1 of 4 DNA mismatch repair genes (MLH1, MSH2, MSH6, or PMS2), or deletions in the EPCAM promoter. Patients with Lynch syndrome are at an increased lifetime risk, compared with the general population, for colorectal cancer, endometrial cancer, and other cancers, including of the stomach and ovary. As of 2016, the panel recommends screening all patients with colorectal cancer for Lynch syndrome and provides recommendations for surveillance for early detection and prevention of Lynch syndrome-associated cancers.

  • 1.

    SiegelRLMillerKDJemalA. Cancer statistics, 2015. CA Cancer J Clin2015;65:529.

  • 2.

    BurtRNeklasonDW. Genetic testing for inherited colon cancer. Gastroenterology2005;128:16961716.

  • 3.

    GiardielloFMOfferhausJG. Phenotype and cancer risk of various polyposis syndromes. Eur J Cancer1995;31A:10851087.

  • 4.

    HamiltonSRLiuBParsonsRE. The molecular basis of Turcot's syndrome. N Engl J Med1995;332:839847.

  • 5.

    AaltonenLASalovaaraRKristoP. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med1998;338:14811487.

    • Search Google Scholar
    • Export Citation
  • 6.

    HampelHFrankelWLMartinE. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med2005;352:18511860.

    • Search Google Scholar
    • Export Citation
  • 7.

    HampelHFrankelWLMartinE. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol2008;26:57835788.

    • Search Google Scholar
    • Export Citation
  • 8.

    LynchHTde la ChapelleA. Hereditary colorectal cancer. N Engl J Med2003;348:919932.

  • 9.

    BolandCRGoelA. Microsatellite instability in colorectal cancer. Gastroenterology2010;138:20732087 e2073.

  • 10.

    KempersMJKuiperRPOckeloenCW. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol2011;12:4955.

    • Search Google Scholar
    • Export Citation
  • 11.

    RumillaKSchowalterKVLindorNM. Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases. J Mol Diagn2011;13:9399.

    • Search Google Scholar
    • Export Citation
  • 12.

    VasenHFWatsonPMecklinJPLynchHT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology1999;116:14531456.

    • Search Google Scholar
    • Export Citation
  • 13.

    VasenHF. Clinical diagnosis and management of hereditary colorectal cancer syndromes. J Clin Oncol2000;18:81S92S.

  • 14.

    BarnetsonRATenesaAFarringtonSM. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med2006;354:27512763.

    • Search Google Scholar
    • Export Citation
  • 15.

    Rodriguez-BigasMABolandCRHamiltonSR. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst1997;89:17581762.

    • Search Google Scholar
    • Export Citation
  • 16.

    UmarABolandCRTerdimanJP. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst2004;96:261268.

    • Search Google Scholar
    • Export Citation
  • 17.

    RaedleJTrojanJBriegerA. Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer. Ann Intern Med2001;135:566576.

    • Search Google Scholar
    • Export Citation
  • 18.

    PinolVCastellsAAndreuM. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA2005;293:19861994.

    • Search Google Scholar
    • Export Citation
  • 19.

    BalmanaJStockwellDHSteyerbergEW. Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA2006;296:14691478.

  • 20.

    ChenSWangWLeeS. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA2006;296:14791487.

  • 21.

    KastrinosFSteyerbergEWMercadoR. The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history. Gastroenterology2011;140:7381.

    • Search Google Scholar
    • Export Citation
  • 22.

    BonadonaVBonaitiBOlschwangS. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA2011;305:23042310.

    • Search Google Scholar
    • Export Citation
  • 23.

    KohlmannWGruberS. Lynch Syndrome. GeneReviews at GeneTests: Medical Genetics Information Resource2014.

  • 24.

    MoreiraLBalaguerFLindorN. Identification of Lynch syndrome among patients with colorectal cancer. JAMA2012;308:15551565.

  • 25.

    Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med2009;11:3541.

    • Search Google Scholar
    • Export Citation
  • 26.

    LadabaumUWangGTerdimanJ. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med2011;155:6979.

    • Search Google Scholar
    • Export Citation
  • 27.

    PalomakiGEMcClainMRMelilloS. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med2009;11:4265.

    • Search Google Scholar
    • Export Citation
  • 28.

    BalmanaJBalaguerFCervantesAArnoldD. Familial risk-colorectal cancer: ESMO Clinical Practice Guidelines. Ann Oncol2013;24Suppl 6:vi7380.

    • Search Google Scholar
    • Export Citation
  • 29.

    GiardielloFMAllenJIAxilbundJE. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastroenterology2014;147:502526.

    • Search Google Scholar
    • Export Citation
  • 30.

    GoodfellowPJBillingsleyCCLankesHA. Combined microsatellite instability, MLH1 methylation analysis, and immunohistochemistry for Lynch syndrome screening in endometrial cancers from GOG210: an NRG Oncology and Gynecologic Oncology Group study. J Clin Oncol2015;33:43014308.

    • Search Google Scholar
    • Export Citation
  • 31.

    MarquezEGengZPassS. Implementation of routine screening for Lynch syndrome in university and safety-net health system settings: successes and challenges. Genet Med2013;15:925932.

    • Search Google Scholar
    • Export Citation
  • 32.

    HendriksYMde JongAEMorreauH. Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians. CA Cancer J Clin2006;56:213225.

    • Search Google Scholar
    • Export Citation
  • 33.

    BolandCRThibodeauSNHamiltonSR. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res1998;58:52485257.

    • Search Google Scholar
    • Export Citation
  • 34.

    XicolaRMLlorXPonsE. Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors. J Natl Cancer Inst2007;99:244252.

    • Search Google Scholar
    • Export Citation
  • 35.

    CaldesTGodinoJSanchezA. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer. Oncol Rep2004;12:621629.

    • Search Google Scholar
    • Export Citation
  • 36.

    VasenHFHendriksYde JongAE. Identification of HNPCC by molecular analysis of colorectal and endometrial tumors. Dis Markers2004;20:207213.

    • Search Google Scholar
    • Export Citation
  • 37.

    HampelHFrankelWPanescuJ. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res2006;66:78107817.

    • Search Google Scholar
    • Export Citation
  • 38.

    LindorNMBurgartLJLeontovichO. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol2002;20:10431048.

    • Search Google Scholar
    • Export Citation
  • 39.

    ReyesCMAllenBATerdimanJPWilsonLS. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness. Cancer2002;95:18481856.

    • Search Google Scholar
    • Export Citation
  • 40.

    ShiaJKlimstraDSNafaK. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am J Surg Pathol2005;29:96104.

    • Search Google Scholar
    • Export Citation
  • 41.

    PinoMSChungDC. Application of molecular diagnostics for the detection of Lynch syndrome. Expert Rev Mol Diagn2010;10:651665.

  • 42.

    StoffelEMManguPBGruberSB. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol2015;33:209217.

    • Search Google Scholar
    • Export Citation
  • 43.

    RubensteinJHEnnsRHeidelbaughJBarkunA. American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Lynch Syndrome. Gastroenterology2015;149:777782.

    • Search Google Scholar
    • Export Citation
  • 44.

    HaraldsdottirSHampelHTomsicJ. Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. Gastroenterology2014;147:13081316.e1301.

    • Search Google Scholar
    • Export Citation
  • 45.

    EngelCLoefflerMSteinkeV. Risks of less common cancers in proven mutation carriers with lynch syndrome. J Clin Oncol2012;30:44094415.

    • Search Google Scholar
    • Export Citation
  • 46.

    KastrinosFMukherjeeBTayobN. Risk of pancreatic cancer in families with Lynch syndrome. JAMA2009;302:17901795.

  • 47.

    WatsonPVasenHFMecklinJP. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer2008;123:444449.

  • 48.

    WinAKYoungJPLindorNM. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol2012;30:958964.

    • Search Google Scholar
    • Export Citation
  • 49.

    WinAKLindorNMYoungJP. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst2012;104:13631372.

    • Search Google Scholar
    • Export Citation
  • 50.

    LindorNMPetersenGMHadleyDW. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA2006;296:15071517.

    • Search Google Scholar
    • Export Citation
  • 51.

    SyngalSBrandREChurchJM. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol2015;110:223262; quiz 263.

    • Search Google Scholar
    • Export Citation
  • 52.

    JenkinsMADowtyJGAit OuakrimD. Short-term risk of colorectal cancer in individuals with lynch syndrome: a meta-analysis. J Clin Oncol2015;33:326331.

    • Search Google Scholar
    • Export Citation
  • 53.

    HaanstraJFKleibeukerJHKoornstraJJ. Role of new endoscopic techniques in Lynch syndrome. Fam Cancer2013;12:267272.

  • 54.

    StoffelEMTurgeonDKStockwellDH. Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer). Cancer Prev Res (Phila)2008;1:470475.

    • Search Google Scholar
    • Export Citation
  • 55.

    ChenLMYangKYLittleSE. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families. Obstet Gynecol2007;110:1825.

    • Search Google Scholar
    • Export Citation
  • 56.

    SchmelerKMLynchHTChenLM. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med2006;354:261269.

    • Search Google Scholar
    • Export Citation
  • 57.

    StucklessSGreenJDawsonL. Impact of gynecological screening in Lynch syndrome carriers with an MSH2 mutation. Clin Genet2013;83:359364.

    • Search Google Scholar
    • Export Citation
  • 58.

    ACOG Practice Bulletin No. 147: Lynch syndrome. Obstet Gynecol2014;124:10421054.

  • 59.

    AuranenAJoutsiniemiT. A systematic review of gynecological cancer surveillance in women belonging to hereditary nonpolyposis colorectal cancer (Lynch syndrome) families. Acta Obstet Gynecol Scand2011;90:437444.

    • Search Google Scholar
    • Export Citation
  • 60.

    JarvinenHJRenkonen-SinisaloLAktan-CollanK. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol2009;27:47934797.

    • Search Google Scholar
    • Export Citation
  • 61.

    Renkonen-SinisaloLButzowRLeminenA. Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome. Int J Cancer2007;120:821824.

    • Search Google Scholar
    • Export Citation
  • 62.

    RijckenFEMouritsMJKleibeukerJH. Gynecologic screening in hereditary nonpolyposis colorectal cancer. Gynecol Oncol2003;91:7480.

  • 63.

    Dove-EdwinIBoksDGoffS. The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma. Cancer2002;94:17081712.

    • Search Google Scholar
    • Export Citation
  • 64.

    DashtiSGChauROuakrimDA. Female hormonal factors and the risk of endometrial cancer in Lynch syndrome. JAMA2015;314:6171.

  • 65.

    CapelleLGVan GriekenNCLingsmaHF. Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology2010;138:487492.

    • Search Google Scholar
    • Export Citation
  • 66.

    SchulmannKEngelCProppingPSchmiegelW. Small bowel cancer risk in Lynch syndrome. Gut2008;57:16291630.

  • 67.

    ten KateGLKleibeukerJHNagengastFM. Is surveillance of the small bowel indicated for Lynch syndrome families?Gut2007;56:11981201.

  • 68.

    KoornstraJJKleibeukerJHVasenHF. Small-bowel cancer in Lynch syndrome: is it time for surveillance?Lancet Oncol2008;9:901905.

  • 69.

    SenterLClendenningMSotamaaK. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology2008;135:419428.

    • Search Google Scholar
    • Export Citation
  • 70.

    Renkonen-SinisaloLSipponenPAarnioM. No support for endoscopic surveillance for gastric cancer in hereditary non-polyposis colorectal cancer. Scand J Gastroenterol2002;37:574577.

    • Search Google Scholar
    • Export Citation
  • 71.

    VasenHFBlancoIAktan-CollanK. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut2013;62:812823.

    • Search Google Scholar
    • Export Citation
  • 72.

    CorreaPHaenszelWCuelloC. A model for gastric cancer epidemiology. Lancet1975;2:5860.

  • 73.

    BlaserMJ. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis1999;179:15231530.

    • Search Google Scholar
    • Export Citation
  • 74.

    JoostPTherkildsenCDominguez-ValentinM. Urinary tract cancer in Lynch syndrome: increased risk in carriers of MSH2 mutations. Urology2015;86:12121217.

    • Search Google Scholar
    • Export Citation
  • 75.

    MorkMHuboskySGRoupretM. Lynch syndrome: a primer for urologists and panel recommendations. J Urol2015;194:2129.

  • 76.

    SkeldonSCSemotiukKAronsonM. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer. Eur Urol2013;63:379385.

    • Search Google Scholar
    • Export Citation
  • 77.

    WinAKLindorNMJenkinsMA. Risk of breast cancer in Lynch syndrome: a systematic review. Breast Cancer Res2013;15:R27.

  • 78.

    HaraldsdottirSHampelHWeiL. Prostate cancer incidence in males with Lynch syndrome. Genet Med2014;16:553557.

  • 79.

    WimmerKKratzCPVasenHF. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘care for CMMRD’ (C4CMMRD). J Med Genet2014;51:355365.

    • Search Google Scholar
    • Export Citation
  • 80.

    BurnJGerdesAMMacraeF. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet2011;378:20812087.

    • Search Google Scholar
    • Export Citation
  • 81.

    MovahediMBishopDTMacraeF. Obesity, aspirin, and risk of colorectal cancer in carriers of hereditary colorectal cancer: a prospective investigation in the CAPP2 study. J Clin Oncol2015.

    • Search Google Scholar
    • Export Citation
  • 82.

    ClelandJG. Does aspirin really reduce the risk of colon cancer?Lancet2012;379:1586; author reply 1587.

  • 83.

    JankowskiJBarrHMoayyediP. Does aspirin really reduce the risk of colon cancer?Lancet2012;379:15861587; author reply 1587.

  • 84.

    Ait OuakrimDDashtiSGChauR. Aspirin, ibuprofen, and the risk of colorectal cancer in Lynch syndrome. J Natl Cancer Inst2015;107.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 680 680 98
PDF Downloads 115 115 13
EPUB Downloads 0 0 0